China Universal Asset Management Co., Ltd. Esperion Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 39,522 shares of ESPR stock, worth $39,522. This represents 0.01% of its overall portfolio holdings.
Number of Shares
39,522
Previous 41,779
5.4%
Holding current value
$39,522
Previous $91,000
38.46%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding ESPR
# of Institutions
210Shares Held
128MCall Options Held
1.78MPut Options Held
1.27M-
Wasatch Advisors Inc Salt Lake City, UT24.5MShares$24.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY14MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$11.7 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$9.94 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.31MShares$6.31 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $66.6M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...